HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoko Hoki Selected Research

NF-kappa B (NF-kB)

11/20078-Nitroguanine as a potential biomarker for progression of malignant fibrous histiocytoma, a model of inflammation-related cancer.
2/2007iNOS-dependent DNA damage in patients with malignant fibrous histiocytoma in relation to prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoko Hoki Research Topics

Disease

3Neoplasms (Cancer)
11/2007 - 12/2006
2Inflammation (Inflammations)
11/2007 - 02/2007
2Hypoxia (Hypoxemia)
11/2007 - 12/2006
2Malignant Fibrous Histiocytoma
11/2007 - 12/2006
2Carcinogenesis
11/2007 - 02/2007
1Tarsal Tunnel Syndrome
01/2008
1Synovial Sarcoma (Synovioma)
12/2006
1Sarcoma (Soft Tissue Sarcoma)
12/2006
1Leiomyosarcoma
12/2006
1Neurofibrosarcoma (MPNST)
12/2006

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
11/2007 - 12/2006
2NitrogenIBA
11/2007 - 02/2007
2Oxygen (Dioxygen)IBA
11/2007 - 02/2007
28-nitroguanineIBA
11/2007 - 02/2007
2NF-kappa B (NF-kB)IBA
11/2007 - 02/2007
1TenascinIBA
01/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2007
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2007
1Proteins (Proteins, Gene)FDA Link
12/2006
1Transcription Factors (Transcription Factor)IBA
12/2006